10x Genomics joins EMBL’s Corporate Partnership Program

–Joining forces for single-cell research excellence– PLEASANTON, CA.—February 21, 2018—10x Genomics, Inc., a company focused on accelerating genomic discovery, today announced that it has joined the Corporate Partnership Program of the European Molecular Biology Laboratory (EMBL), one of the world’s leading research institutions. “As a leader in single cell genomics, 10x Genomics is investing in... Read more

Anton Paar Acquires Quantachrome Instruments

2018-02-09 Quantachrome and Anton Paar finished the purchasing process on February 9 at the Quantachrome headquarters in Boynton Beach, Florida. The companies agreed not to disclose the purchase price. Under the umbrella of the Anton Paar Group, the company will continue operations in Boynton Beach. Georg Cortolezis-Supp, Executive Director Production & Purchasing at Anton Paar, will manage the... Read more

Bruker Corporation to Present at the LEERINK Partners 7th Annual Global Healthcare Conference

BILLERICA, Mass., Feb. 9, 2018 /PRNewswire/ — Bruker Corporation (NASDAQ: BRKR) announced today it will present at the LEERINK Partners 7th Annual Global Healthcare Conference. Frank Laukien, President and CEO, will participate in a “fireside chat” Q&A session on behalf of the company on Wednesday, February 14th, 2018 at 9:30 AM Eastern Time.   A live audio... Read more

Fujifilm and Takeda Announce Collaboration to Develop Regenerative Medicine Therapies using Cardiomyocytes Derived from iPSC

Order Contact Careers Account Log In/Register Why CDI Partners & Providers Our Technology Cellular Therapy Drug Discovery Health & Nutrition Stem Cell Banking Products & Services iCell Products iCell Astrocytes iCell Cardiac Progenitor Cells iCell Cardiomyocytes iCell Cardiomyocytes2 iCell DopaNeurons iCell Endothelial Cells iCell GABANeurons iCell GlutaNeurons iCell Hematopoietic Progenitor Cells iCell Hepatoblasts iCell Hepatocytes... Read more

Ocean Optics Develops Mid-IR Sensing Capabilities in Partnership with Pyreos

February 8, 2018 Ocean Optics has expanded its spectroscopy capabilities by partnering with Pyreos Limited (Edinburgh, Scotland) to develop new mid-IR solutions. Unlike traditional FT-IR spectrometers, the unique combination of Pyreos’ detectors and Ocean Optics applied spectroscopy knowledge will enable businesses and researchers to create rapid, accurate and field-portable devices. MIR technology makes possible a wealth of... Read more

Roche purchases shares in tender offer for Ignyta, Inc.

Basel, 08 February 2018 Roche purchases shares in tender offer for Ignyta, Inc. Roche (SIX: RO, ROG; OTCQX: RHHBY) and Ignyta, Inc. today announced that Roche’s wholly owned subsidiary Abingdon Acquisition Corp., has accepted for payment all shares validly tendered and not validly withdrawn pursuant to its tender offer for all outstanding shares of common... Read more

Roche purchases shares in tender offer for Ignyta, Inc.

Basel, 08 February 2018 Roche purchases shares in tender offer for Ignyta, Inc. Roche (SIX: RO, ROG; OTCQX: RHHBY) and Ignyta, Inc. today announced that Roche’s wholly owned subsidiary Abingdon Acquisition Corp., has accepted for payment all shares validly tendered and not validly withdrawn pursuant to its tender offer for all outstanding shares of common... Read more

Roche purchases shares in tender offer for Ignyta, Inc.

Basel, 08 February 2018 Roche purchases shares in tender offer for Ignyta, Inc. Roche (SIX: RO, ROG; OTCQX: RHHBY) and Ignyta, Inc. today announced that Roche’s wholly owned subsidiary Abingdon Acquisition Corp., has accepted for payment all shares validly tendered and not validly withdrawn pursuant to its tender offer for all outstanding shares of common... Read more

Luminex Corporation To Present At LEERINK Partners 7th Annual Global Healthcare Conference

AUSTIN, Texas, Feb. 6, 2018 /PRNewswire/ — Luminex Corporation (NASDAQ: LMNX) today announced that management will present at the LEERINK Partners 7th Annual Global Healthcare Conference to be held February 14-15, 2018, in New York, NY. The investor presentation will begin at 10:30 a.m. Eastern time on Thursday, February 15, 2018.  The presentation will be webcast live... Read more